Loading...
B cells for cancer immunotherapy
We have engineered a novel fusion cytokine named GIFT4 derived from GM-CSF and IL-4, and displaying robust gain-of-function immunostimulatory effects on B cells. GIFT4-programmed B cells have a unique identity and potent capacity to elicit a tumoricidal - cell response, thus comprising a novel B cel...
Na minha lista:
| Udgivet i: | Oncoimmunology |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4292730/ https://ncbi.nlm.nih.gov/pubmed/25941574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.955702 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|